Pierre Fabre inaugurates Pierre Fabre China Innovation Center, a new dermo-cosmetics innovation and research center in Shanghai; research center will focus on specificities of Asian skin and hair, boosting competitiveness of Pierre Fabre's brands in Asia

Sample article from our Beauty & Personal Care

SHANGHAI , June 9, 2023 (press release) –

Shanghai, Castres, June 9, 2023 After France and Brazil, Pierre Fabre has just inaugurated its new dermo-cosmetics innovation and research center in China: “Pierre Fabre China Innovation Center”. The CIC is based in Shanghai, in the district of Pudong, the nerve center of new technologies and research.

During this inauguration, which was held in the presence of Mr. Yuan Yefeng, Deputy Director of Shanghai Pudong Free Trade Zone Lujiazui Management Bureau, and Mr. Joan Valadou, Consul General of the French Consulate in Shanghai, Eric Ducournau, CEO Pierre Fabre Group, declared:

 

In the past years, we collaborated with the Beijing University Hospital, among others, to conduct research in dermatology, deepen our knowledge of the specificities of Asian skin, and learn about the needs of Chinese patients and consumers. The establishment of the China Innovation Center, which we are proud to inaugurate today, is a milestone for us. It will serve as a catalyst for innovation and competitiveness in the Chinese market and more broadly in the Asian market.

Eric Ducournau,
CEO Pierre Fabre Group

 

Pierre Fabre China is today the first international subsidiary of the group's dermo-cosmetics business, driven by the performance of three complementary brands among the six of the global portfolio: Eau Thermale Avène, with medical DNA, Klorane, specialist in healing properties of plants and René Furterer, the expert professional hair care brand.

The China Innovation Center will strengthen the presence of these brands in China and guarantee their development on the Asian cosmetics market with its tremendous potential. With an Avène product sold every 5 seconds, China is one of the main contributors that will enable the brand to reach one billion euros by the end of the year.

Frédéric Ennabli, CEO Pierre Fabre Dermo-Cosmetics, declares:

 

This new innovation center will enable us to be as close as possible to consumers, dermatologists and health professionals, to better study the specificities of Chinese consumer skin and hair, and thus understand which formulas best meet their needs. This project is perfectly in line with our mission: to serve our patients and consumers through innovative and effective solutions, to care for and treat pathologies, and thus improve their daily lives. Finally, the inauguration of this center is emblematic of Pierre Fabre's attachment to China, we are indeed celebrating the 20th anniversary of the launch of Eau Thermale Avène in China with the iconic cream for Intolerant Skin which has now become Tolerance Repair

Frédéric Ennabli
CEO Pierre Fabre Dermo-Cosmetics

The Pierre Fabre China Innovation Center includes a formulation laboratory and a space dedicated to consumer testing. It will host a multidisciplinary team made up of scientists, researchers and technicians, specializing in biomedical and pharmacological innovation.

Anne-Laure Gaudry, Director of the Pierre Fabre Dermo-Cosmetics International Innovation Centers, explains:

 

Thanks to our medical and scientific expertise as well as our know-how in formulation, tomorrow the Eau Thermale Avène, Klorane and René Furterer brands will develop unique, innovative and effective products, thanks to specific technologies, while guaranteeing transparency and sustainable sourcing, which will be check by the Green Impact Index, a rating tool that measures and communicates by A, B, C, D or E, the environmental and societal impact of our products.

Anne-Laure Gaudry
Director of the Pierre Fabre Dermo-Cosmetics International Innovation Centers

About Pierre Fabre

Pierre Fabre is the 2nd largest dermo-cosmetics laboratory in the world and the 2nd largest private pharmaceutical group in France.  Its portfolio includes several medical franchises and international brands, including Pierre Fabre Oncology, Pierre Fabre Dermatology, Eau Thermale AvèneKloraneDucrayRené FurtererA-DermaDarrowGlytoneNaturactive and Pierre Fabre Oral Care. In 2021, Pierre Fabre posted 2.5 billion euros in revenues, 66% of which came from international sales in over 100 countries. Established in the South-West of France since its creation, and manufacturing over 95% of its products in France, the Group employs some 9,500 people worldwide.  86% of the Pierre Fabre Group is held by the Pierre Fabre Foundation, a government-recognized public-interest foundation since 1999, and secondarily by its employees via an employee stock ownership plan.

www.pierre-fabre.com, @PierreFabre

Contact

Dorothée Kohler, responsable des relations presse Groupe 

dorothee.kohler@pierre-fabre.com

06 08 09 22 41

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order beauty & personal care coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.